Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (41 ops.)
Latest filing published 17 Feb 2026 for ALNYLAM PHARMACEUTICALS, INC.. Read the official filing
Filing timeline
BuySalePushkal Garg
Insider track record
Disclosed buys
0
Disclosed sells
41
T+90 hit rate
76%
T+90 mean return
+15.7%
Across 17 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Pushkal Garg: trading record in brief
This profile gathers the share dealings of Pushkal Garg in Alnylam Pharmaceuticals, Inc. Between 3 August 2022 and 4 March 2026, the trades on record add up to 63 filings.
On the market, this insider has only sold: 41 sales, €8.7M in total. Outside the open market, there are 15 share grants and 7 option exercises. In 2026 alone, the filings show no purchases and 2 sales.
On 6 March 2026 came the latest disclosure, an open-market sale for €29k in Alnylam Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Pushkal Garg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations59 total
4,579 shares0Common StockSEC:0001735276-26-000029:0
2,242 shares@ US$310.08085.1% of flowCommon StockSEC:0001735276-26-000029:1
3,108 shares0Common StockSEC:0001735276-25-000113:0
2,851 shares0Common StockSEC:0001735276-25-000092:0
39 shares@ US$447.980.1% of flowCommon StockSEC:0001735276-25-000092:1
90 shares@ US$449.920.3% of flowCommon StockSEC:0001735276-25-000092:2
39 shares@ US$450.920.1% of flowCommon StockSEC:0001735276-25-000092:3
103 shares@ US$451.990.3% of flowCommon StockSEC:0001735276-25-000092:4
329 shares@ US$452.961.1% of flowCommon StockSEC:0001735276-25-000092:5
543 shares@ US$454.041.9% of flowCommon StockSEC:0001735276-25-000092:6
241 shares@ US$454.840.8% of flowCommon StockSEC:0001735276-25-000092:7
12 shares@ US$455.820.0% of flowCommon StockSEC:0001735276-25-000092:8
276 shares@ US$455.410.9% of flowCommon StockSEC:0001735276-25-000092:9
338 shares@ US$457.261.2% of flowCommon StockSEC:0001735276-25-000092:10
231 shares@ US$458.270.8% of flowCommon StockSEC:0001735276-25-000092:11
260 shares@ US$459.590.9% of flowCommon StockSEC:0001735276-25-000092:12
305 shares@ US$461.011.1% of flowCommon StockSEC:0001735276-25-000092:13
45 shares@ US$461.740.2% of flowCommon StockSEC:0001735276-25-000092:14
4,321 shares@ US$285.009.9% of flowCommon StockSEC:0001735276-25-000041:0
5,445 shares@ US$42.221.9% of flowCommon StockSEC:0001735276-25-000041:1
5,445 shares@ US$300.0013.2% of flowCommon StockSEC:0001735276-25-000041:2
14,137 shares0Common StockSEC:0001735276-25-000032:0
1,908 shares0Common StockSEC:0001735276-25-000020:0
3,109 shares0Common StockSEC:0001735276-25-000009:0
349 shares@ US$252.500.7% of flowCommon StockSEC:0001735276-25-000009:1
25 of 59 declarations
